title: New data on the occurrence of ochratoxin A in human sera from patients affected or not by renal diseases in Tunisia.
abstract: Ochratoxin A is often found in the sera of people exposed to this mycotoxin in their food (cereals such as barley, coffee, wines, fruit juices, spices, products of animal origin such as pig and poultry offal). Ochratoxin A is suspected of playing a role in the Balkan Endemic Nephropathy, a nephropathology described in Balkan areas where ochratoxin A is often found in cereals and in pork-derived products. In North Africa like Tunisia where high incidence of chronic interstitial nephropathies of unknown aetiology are pointed out, the involvement of ochratoxin A was suspected but contradictory studies on the degree of human exposure did not succeed in evidencing the role of ochratoxin A. In the present work, sera from 47 volunteers hospitalised for nephropathic damages including bladder tumours (21 people), and from 62 patients hospitalised for disorders other than nephropathic ones, were analysed for ochratoxin A contents. The determination of ochratoxin A in sera was done by a validated immunoaffinity-HPLC method. Sera from unaffected population exhibited percentages of 74.2%, 22.6% and 3.2% containing ranges of ochratoxin A as <0.10-0.5 microg/l, 0.51-1.0 microg/l and above 1.0 microg/l respectively. For patients affected with renal diseases, percentages were 59.5%, 25.5% and 14.9% on the same ranges of ochratoxin A levels respectively. The average ochratoxin A concentration for patients with urinary tract disease excluding cancer patients was 0.99+/-1.28 microg/l while that for the non-nephropathic patients was 0.53+/-1.00 microg/l. However the average levels in the cancer patients was only 0.26+/-0.20 microg/l. Those results are in line with most of previously published works and did not confirm very high ochratoxin A contents found in other reports from same regions.
authors.affiliation: Agence Française de Sécurité Sanitaire des Aliments, Microbial Toxins Unit, Paris, France.
authors.forename: F
authors.initials: F
authors.lastname: Grosso
authors.forename: S
authors.initials: S
authors.lastname: Saíd
authors.forename: I
authors.initials: I
authors.lastname: Mabrouk
authors.forename: J M
authors.initials: JM
authors.lastname: Fremy
authors.forename: M
authors.initials: M
authors.lastname: Castegnaro
authors.forename: M
authors.initials: M
authors.lastname: Jemmali
authors.forename: S
authors.initials: S
authors.lastname: Dragacci
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000915:Antibody Affinity; D001449:Balkan Nephropathy / Q000097:blood* / Q000453:epidemiology / Q000209:etiology; D002846:Chromatography, Affinity; D002851:Chromatography, High Pressure Liquid; D004781:Environmental Exposure / Q000032:analysis*; D004784:Environmental Monitoring / Q000379:methods*; D062665:Epidemiological Monitoring; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009183:Mycotoxins / Q000097:blood* / Q000302:isolation & purification; D009793:Ochratoxins / Q000097:blood* / Q000302:isolation & purification; D014416:Tunisia / Q000453:epidemiology
chemical_list: D009183:Mycotoxins; D009793:Ochratoxins; C025589:ochratoxin A